Trial intelligence / Profile preview

Antioxidant Micronutrients in Malaria

NCT01152931Phase 3Completed

Sponsor
University of Lagos
Start
Aug 2010
Primary completion
Nov 2010
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, open-label trial of vitamin a, vitamin e, zinc and selenium in malaria (15 arms), sponsored by University of Lagos. Primary endpoint: 7-day cure rate at 4 weeks. Started Aug 2010; status: completed.

02

Drugs

vitamin avitamin ezincselenium
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01152931.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01152931.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call